Tag : Demonstrates

Latest News

Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates Continued Survival Benefit at 42-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Newsemia
PRINCETON, N.J.–(BUSINESS WIRE)—- $BMY #BMS–Opdivo Plus Yervoy Demonstrates Continued Survival Benefit at 42-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic RCC Source link...
Biology

5-Year Follow-Up Outpatient of L4-L5 Fixation with Inspan Device for Degenerative Spinal Stenosis Demonstrates Improved Results

Newsemia
BOSTON (PRWEB) February 11, 2020 INSPAN LLC (a privately-owned company) is pleased to announce the successful results from a long-term follow-up clinical study of outpatient...
Gastroenterology

P156 ALPN-101, A FIRST-IN-CLASS DUAL ICOS/CD28 ANTAGONIST, DEMONSTRATES EFFICACY IN PATIENT-DERIVED PBMC IN VITRO AND IN AN IN VIVO T CELL TRANSFER MODEL OF CHRONIC INFLAMMATORY BOWEL DISEASE (IBD)

Newsemia
T cell costimulation has been strongly implicated in the pathogenesis of IBD, yet CD28 costimulatory pathway inhibitors (e.g. abatacept, CTLA4-Fc) have not proven clinically efficacious,...
Pediatrics

How an Electronic Medical Record System Facilitates and Demonstrates Effective Psychosocial Screening in Pediatric Primary Care

Newsemia
Clinical Pediatrics, Ahead of Print. Using questionnaires, administrative claims, and chart review data, the current study explored the impact of using an electronic medical record...
Gastroenterology

Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight loss

Newsemia
Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight loss Source link...
Latest News

CORRECTING and REPLACING CAPTION FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival

Newsemia
DETROIT–(BUSINESS WIRE)–Physicians who followed the FDA’s approved protocol for Impella RP use achieved 72% patient survival and 88% native heart recovery. Source link...
Latest News

ESMO 2019: Forbius Demonstrates Target Engagement in Phase 1 Immuno-Oncology Clinical Trial with AVID200, First-in-Class TGF-beta 1 & 3 Inhibitor

Newsemia
AUSTIN, Texas & MONTREAL–(BUSINESS WIRE)– #Austin–Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, today reported results from its non-clinical...
Latest News

Study Demonstrates Significantly Better Quality Cancer Care and Lower Costs with a Value-Based Care Model Implemented by The Oncology Institute and CareMore Health

Newsemia
CERRITOS, Calif.–(BUSINESS WIRE)–The Oncology Institute (TOI), in collaboration with the Stanford University School of Medicine and CareMore Health, today announced data from a study, Enhancing...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy